(Q38074884)

28 August 2017

1 reference

title

A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job. (English)

1 reference

28 August 2017

1 reference

2

1 reference

28 August 2017

Shao-Long Chen

1

1 reference

28 August 2017

Ke-Qing Shi

series ordinal

3

1 reference

28 August 2017

Tao Yang

series ordinal

4

1 reference

28 August 2017

Yong-Ping Chen

series ordinal

5

1 reference

28 August 2017

publication date

1 February 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

27

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

25-34

1 reference

Non-alcoholic steatohepatitis

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Liver transplantation: an update 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Getting to the root of miRNA-mediated gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Widespread changes in protein synthesis induced by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Autoregulatory mechanisms controlling the microprocessor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

MicroRNAs: key modulators of posttranscriptional gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Therapeutic RNA manipulation in liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

The impact of microRNAs on protein output

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Downregulation of miR-122 in the rodent and human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Silencing of microRNAs in vivo with 'antagomirs'

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

MicroRNAs and the regulation of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

MicroRNA-29, a key regulator of collagen expression in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

miR-29 is a major regulator of genes associated with pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

MicroRNA-21: a novel therapeutic target in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

The roles of microRNAs in heart diseases: a novel important regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

miR-21 as a key regulator of oncogenic processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

The role of epithelial-to-mesenchymal transition in renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

A synthetic inhibitor of the mitogen-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

miR-122, a paradigm for the role of microRNAs in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Hepatic stellate cell (vitamin A-storing cell) and its relative--past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Hepatic stellate cell: a star cell in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Transcriptional regulation of hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Advances in antifibrotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

TGF-β in progression of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Fascin, a novel marker of human hepatic stellate cells, may regulate their proliferation, migration, and collagen gene expression through the FAK-PI3K-Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Role of integrins in fibrosing liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Liver fibrosis: cellular mechanisms of progression and resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Hepatic stellate cells and the reversal of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Senescence of activated stellate cells limits liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Senescent cells as a source of inflammatory factors for tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Mechanisms of cellular senescence in human and mouse cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

MicroRNA-based therapeutics for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Hepatic stellate cell-specific gene silencing induced by an artificial microRNA for antifibrosis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

The bone marrow functionally contributes to liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

GFAP promoter directs lacZ expression specifically in a rat hepatic stellate cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

GFAP promoter-driven RNA interference on TGF-β1 to treat liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

CSRP2, TIMP-1, and SM22alpha promoter fragments direct hepatic stellate cell-specific transgene expression in vitro, but not in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40259-012-0005-2

10.1007/S40259-012-0005-2

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference